The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19

[1]  Yadan Wang,et al.  Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study , 2020, The Lancet Haematology.

[2]  A. Peters,et al.  Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[3]  W. Liang,et al.  Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China , 2020, Journal of Allergy and Clinical Immunology.

[4]  C. Bachert,et al.  Perspective: COVID-19, implications of nasal diseases and consequences for their management , 2020, Journal of Allergy and Clinical Immunology.

[5]  R. Carlier,et al.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study , 2020, European Archives of Oto-Rhino-Laryngology.

[6]  R. Schleimer,et al.  Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin. , 2020, The Journal of allergy and clinical immunology.

[7]  M. Fine,et al.  Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America , 2019, American journal of respiratory and critical care medicine.

[8]  C. Ou,et al.  Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities , 2015, Allergy.

[9]  Geng Xu,et al.  Aspirin-exacerbated respiratory disease in China: A cohort investigation and literature review , 2012, American journal of rhinology & allergy.